EGF Signaling Promotes the Lineage Conversion of Astrocytes into Oligodendrocytes

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2022 May 5

PMID 35508991

Authors

Xinyu Liu

Conghui Li

Jiao Li

Lesi Xie

Zeng Hong

Kang Zheng

Xiaofeng Zhao

Aifen Yang

Xiaofeng Xu

Huaping Tao

Mengsheng Qiu

Junlin Yang

Affiliations

Soon will be listed here.

Abstract

Background: The conversion of astrocytes activated by nerve injuries to oligodendrocytes is not only beneficial to axonal remyelination, but also helpful for reversal of glial scar. Recent studies have shown that pathological niche promoted the Sox10-mediated astrocytic transdifferentiation to oligodendrocytes. The extracellular factors underlying the cell fate switching are not known.

Methods: Astrocytes were obtained from mouse spinal cord dissociation culture and purified by differential adherent properties. The lineage conversion of astrocytes into oligodendrocyte lineage cells was carried out by Sox10-expressing virus infection both in vitro and in vivo, meanwhile, epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) inhibitor Gefitinib were adopted to investigate the function of EGF signaling in this fate transition process. Pharmacological inhibition analyses were performed to examine the pathway connecting the EGF with the expression of oligodendrogenic genes and cell fate transdifferentiation.

Results: EGF treatment facilitated the Sox10-induced transformation of astrocytes to O4 induced oligodendrocyte precursor cells (iOPCs) in vitro. The transdifferentiation of astrocytes to iOPCs went through two distinct but interconnected processes: (1) dedifferentiation of astrocytes to astrocyte precursor cells (APCs); (2) transformation of APCs to iOPCs, EGF signaling was involved in both processes. And EGF triggered astrocytes to express oligodendrogenic genes Olig1 and Olig2 by activating extracellular signal-regulated kinase 1 and 2 (Erk1/2) pathway. In addition, we discovered that EGF can enhance astrocyte transdifferentiation in injured spinal cord tissues.

Conclusions: These findings provide strong evidence that EGF facilitates the transdifferentiation of astrocytes to oligodendrocytes, and suggest that targeting the EGF-EGFR-Erk1/2 signaling axis may represent a novel therapeutic strategy for myelin repair in injured central nervous system (CNS) tissues.

Citing Articles

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.

Characterizing progenitor cells in developing and injured spinal cord: Insights from single-nucleus transcriptomics and lineage tracing.

Zhang Q, Wu X, Fan Y, Zhang H, Yin M, Xue X Proc Natl Acad Sci U S A. 2025; 122(2):e2413140122.

PMID: 39761400 PMC: 11745359. DOI: 10.1073/pnas.2413140122.

Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment.

Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Stover D Neuro Oncol. 2024; 27(2):430-444.

PMID: 39367624 PMC: 11812052. DOI: 10.1093/neuonc/noae207.

Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice.

Hamidi S, Etebar N, Rahimzadegan M, Zali A, Roodsari S, Niknazar S Mol Cell Biochem. 2024; 479(7):1643-1671.

PMID: 38977625 DOI: 10.1007/s11010-024-05051-8.

Oligodendrocyte Progenitors in Glial Scar: A Bet on Remyelination.

Marangon D, Castro E Silva J, Cerrato V, Boda E, Lecca D Cells. 2024; 13(12.

PMID: 38920654 PMC: 11202012. DOI: 10.3390/cells13121024.

References

Liu Z, Hu X, Cai J, Liu B, Peng X, Wegner M . Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol. 2006; 302(2):683-93. DOI: 10.1016/j.ydbio.2006.10.007. View

Ding Z, Dai C, Zhong L, Liu R, Gao W, Zhang H . Neuregulin-1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury. Biomed Pharmacother. 2021; 134:111168. DOI: 10.1016/j.biopha.2020.111168. View

Zhou Q, Anderson D . The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell. 2002; 109(1):61-73. DOI: 10.1016/s0092-8674(02)00677-3. View

Pesaresi M, Sebastian-Perez R, Cosma M . Dedifferentiation, transdifferentiation and cell fusion: in vivo reprogramming strategies for regenerative medicine. FEBS J. 2018; 286(6):1074-1093. DOI: 10.1111/febs.14633. View

Huang H, Rubenstein J, Qiu M . Cracking the Codes of Cortical Glial Progenitors: Evidence for the Common Lineage of Astrocytes and Oligodendrocytes. Neurosci Bull. 2021; 37(6):437-439. PMC: 8055804. DOI: 10.1007/s12264-021-00675-y. View

Liu B, Neufeld A . Activation of epidermal growth factor receptors in astrocytes: from development to neural injury. J Neurosci Res. 2007; 85(16):3523-9. DOI: 10.1002/jnr.21364. View

Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y . The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol. 2002; 12(13):1157-63. DOI: 10.1016/s0960-9822(02)00926-0. View

Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

Allen N, Lyons D . Glia as architects of central nervous system formation and function. Science. 2018; 362(6411):181-185. PMC: 6292669. DOI: 10.1126/science.aat0473. View

10.

Najm F, Lager A, Zaremba A, Wyatt K, Caprariello A, Factor D . Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. Nat Biotechnol. 2013; 31(5):426-33. PMC: 3678540. DOI: 10.1038/nbt.2561. View

11.

Galvez-Contreras A, Quinones-Hinojosa A, Gonzalez-Perez O . The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. Front Cell Neurosci. 2014; 7:258. PMC: 3865447. DOI: 10.3389/fncel.2013.00258. View

12.

Scafidi J, Hammond T, Scafidi S, Ritter J, Jablonska B, Roncal M . Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature. 2014; 506(7487):230-4. PMC: 4106485. DOI: 10.1038/nature12880. View

13.

Alexeeva N, Broton J, Calancie B . Latency of changes in spinal motoneuron excitability evoked by transcranial magnetic brain stimulation in spinal cord injured individuals. Electroencephalogr Clin Neurophysiol. 1998; 109(4):297-303. DOI: 10.1016/s0924-980x(98)00021-6. View

14.

Fu Y, Yang M, Yu H, Wang Y, Wu X, Yong J . Heterogeneity of glial progenitor cells during the neurogenesis-to-gliogenesis switch in the developing human cerebral cortex. Cell Rep. 2021; 34(9):108788. DOI: 10.1016/j.celrep.2021.108788. View

15.

Jiang Q, Wang J, Jiang S, Wen L, Zhou H . [Large-scale real-time titration of green-fluorescence-protein-marked recombinant retrovirus: comparison with standard titration method]. Di Yi Jun Yi Da Xue Xue Bao. 2003; 23(10):1101-3. View

16.

Yang Y, Lewis R, Miller R . Interactions between oligodendrocyte precursors control the onset of CNS myelination. Dev Biol. 2010; 350(1):127-38. PMC: 3032606. DOI: 10.1016/j.ydbio.2010.11.028. View

17.

Lu Q, Sun T, Zhu Z, Ma N, Garcia M, Stiles C . Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell. 2002; 109(1):75-86. DOI: 10.1016/s0092-8674(02)00678-5. View

18.

Gledhill R, Harrison B, McDonald W . Demyelination and remyelination after acute spinal cord compression. Exp Neurol. 1973; 38(3):472-87. DOI: 10.1016/0014-4886(73)90169-6. View

19.

Ahn Y, Lee G, Kang S . Molecular insights of the injured lesions of rat spinal cords: Inflammation, apoptosis, and cell survival. Biochem Biophys Res Commun. 2006; 348(2):560-70. DOI: 10.1016/j.bbrc.2006.07.105. View

20.

Starossom S, Campo Garcia J, Woelfle T, Romero-Suarez S, Olah M, Watanabe F . Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation. Nat Commun. 2019; 10(1):217. PMC: 6333780. DOI: 10.1038/s41467-018-08140-7. View